SCHEMBL4906296

SCHEMBL4906296

CCN(Sc1ccc(C(C)C)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
TSHR P16473 3/20 0.48
HCRTR1 O43613 2/20 0.38
HCRTR2 O43614 1/20 0.38
MAPT P10636 3/20 0.37
KDM4E B2RXH2 1/20 0.37
CYP2C9 P11712 2/20 0.36
BCHE P06276 2/20 0.36
ACHE P22303 2/20 0.36
LMNA P02545 2/20 0.36
BMP1 P13497 2/20 0.35
HPGD P15428 2/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902927 0.89 ALDH1A1 (0.48) ALDH1A1TSHRHCRTR1HCRTR2MAPT
SCHEMBL4899391 0.89 LMNA (0.42) ALDH1A1TSHRHCRTR1HCRTR2KDM4E
SCHEMBL4905286 0.88 TSHR (0.42) ALDH1A1TSHRHCRTR1HCRTR2MAPT
SCHEMBL4894507 0.88 ALDH1A1 (0.48) ALDH1A1TSHRHCRTR1HCRTR2MAPT
SCHEMBL4905613 0.88 ALDH1A1 (0.48) ALDH1A1TSHRHCRTR1MAPTKDM4E
SCHEMBL4899260 0.85 ALDH1A1 (0.46) ALDH1A1TSHRHCRTR2MAPTCYP2C9
SCHEMBL4905869 0.85 ALDH1A1 (0.42) ALDH1A1TSHRMAPTCYP2C9LMNA
SCHEMBL4906682 0.85 ALDH1A1 (0.48) ALDH1A1TSHRMAPTCYP2C9LMNA
SCHEMBL4902853 0.84 ALDH1A1 (0.45) ALDH1A1TSHRMAPTKDM4ECYP2C9
SCHEMBL4906048 0.84 ALDH1A1 (0.45) ALDH1A1TSHRHCRTR1HCRTR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885HCRTR1 4146/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885HCRTR1 4148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.